Related Experiment Video
Updated: May 16, 2026

Blastomere Explants to Test for Cell Fate Commitment During Embryonic Development
Published on: January 26, 2013
p27(Kip1) directly represses Sox2 during embryonic stem cell differentiation
Han Li1, Manuel Collado, Aranzazu Villasante
1Tumor Suppression Group, Spanish National Cancer Research Centre, Madrid, E28029, Spain.
Abstract:
The mechanisms responsible for the transcriptional silencing of pluripotency genes in differentiated cells are poorly understood. We have observed that cells lacking the tumor suppressor p27 can be reprogrammed into induced pluripotent stem cells (iPSCs) in the absence of ectopic Sox2. Interestingly, cells and tissues from p27 null mice, including brain, lung, and retina, present an elevated basal expression of Sox2, suggesting that p27 contributes to the repression of Sox2. Furthermore, p27 null iPSCs fail to fully repress Sox2 upon differentiation. Mechanistically, we have found that upon differentiation p27 associates to the SRR2 enhancer of the Sox2 gene together with a p130-E2F4-SIN3A repressive complex. Finally, Sox2 haploinsufficiency genetically rescues some of the phenotypes characteristic of p27 null mice, including gigantism, pituitary hyperplasia, pituitary tumors, and retinal defects. Collectively, these results demonstrate an unprecedented connection between p27 and Sox2 relevant for reprogramming and cancer and for understanding human pathologies associated with p27 germline mutations.
Insights
The tumor suppressor p27 (also known as CDKN1B) is crucial for repressing the pluripotency gene Sox2 during cell differentiation. Loss of p27 facilitates reprogramming and impacts development and cancer.
Area of Science:
- Cell Biology
- Developmental Biology
- Cancer Biology
Background:
- Transcriptional silencing of pluripotency genes is key for cell differentiation.
- Mechanisms controlling Sox2 expression during differentiation are not fully understood.
Purpose of the Study:
- To investigate the role of the tumor suppressor p27 in regulating Sox2 expression.
- To explore the implications of the p27-Sox2 interaction in cell reprogramming and disease.
Main Methods:
- Analysis of p27 null mice and derived induced pluripotent stem cells (iPSCs).
- Chromatin immunoprecipitation to identify protein-DNA interactions at the Sox2 locus.
- Genetic rescue experiments using Sox2 haploinsufficiency.
Main Results:
- p27 null cells exhibit elevated basal Sox2 expression and impaired Sox2 repression during differentiation.
- p27 interacts with a p130-E2F4-SIN3A complex at the Sox2 SRR2 enhancer.
- Sox2 haploinsufficiency ameliorates p27 null phenotypes, including gigantism and tumors.
Conclusions:
- p27 acts as a critical repressor of Sox2 during differentiation.
- The p27-Sox2 axis is vital for normal development, cell reprogramming, and cancer prevention.
- Dysregulation of p27 impacts human pathologies associated with germline mutations.
Related Concept Videos
Somatic to iPS Cell Reprogramming
Maintenance of the ES Cell State
Methods of Nuclear Reprogramming
Master Transcription Regulators
Pleiotropy
Inheritance of Chromatin Structures
